Fresenius Se Co Stock Performance
| FSNUY Stock | USD 8.83 0.12 1.38% |
The firm shows a Beta (market volatility) of 0.61, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fresenius' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fresenius is expected to be smaller as well. At this point, Fresenius SE has a negative expected return of -0.0592%. Please make sure to confirm Fresenius' skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Fresenius SE performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Fresenius SE Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresenius is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -2.8 B |
Fresenius |
Fresenius Relative Risk vs. Return Landscape
If you would invest 921.00 in Fresenius SE Co on August 31, 2024 and sell it today you would lose (38.00) from holding Fresenius SE Co or give up 4.13% of portfolio value over 90 days. Fresenius SE Co is currently producing negative expected returns and takes up 1.2445% volatility of returns over 90 trading days. Put another way, 11% of traded pink sheets are less volatile than Fresenius, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Fresenius Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Fresenius SE Co, and traders can use it to determine the average amount a Fresenius' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0476
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FSNUY |
Estimated Market Risk
| 1.24 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fresenius is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresenius by adding Fresenius to a well-diversified portfolio.
Fresenius Fundamentals Growth
Fresenius Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Fresenius, and Fresenius fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresenius Pink Sheet performance.
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 43.74 B | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 7.33 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 37.52 B | |||
| EBITDA | 2.65 B | |||
| Cash And Equivalents | 2.13 B | |||
| Cash Per Share | 0.94 X | |||
| Total Debt | 27.16 B | |||
| Debt To Equity | 0.89 % | |||
| Book Value Per Share | 9.49 X | |||
| Cash Flow From Operations | 5.08 B | |||
| Earnings Per Share | 0.77 X | |||
| Total Asset | 71.96 B | |||
| Current Asset | 12.51 B | |||
| Current Liabilities | 9.5 B | |||
About Fresenius Performance
Evaluating Fresenius' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Fresenius has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fresenius has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people.Things to note about Fresenius SE performance evaluation
Checking the ongoing alerts about Fresenius for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Fresenius SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fresenius SE generated a negative expected return over the last 90 days |
- Analyzing Fresenius' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresenius' stock is overvalued or undervalued compared to its peers.
- Examining Fresenius' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresenius' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresenius' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresenius' pink sheet. These opinions can provide insight into Fresenius' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fresenius Pink Sheet Analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.